Related content

Cardiovascular effects of verapamil enantiomer combinations in conscious dogs

By Pagel P.S.   Hettrick D.A.   Lowe D.   Gowrie P.W.   Kersten J.R.   Bosnjak Z.J.   Warltier D.C.  

European Journal of Pharmacology, Vol. 348, Iss. 2, 1998-05 ,pp. : 213-221

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics of verapamil and norverapamil from controlled release floating pellets in humans

By Sawicki W.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 53, Iss. 1, 2002-01 ,pp. : 29-35

Elsevier

Access to resources Recommend Favorite

Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose–effect study

By Hasler Felix   Grimberg Ulrike   Benz Marco   Huber Theo   Vollenweider Franz  

Psychopharmacology, Vol. 172, Iss. 2, 2004-03 ,pp. : 145-156

Springer Publishing Company

Access to resources Recommend Favorite

A placebo-controlled study of sildenafil effects on cognition in schizophrenia

By Goff Donald   Cather Corinne   Freudenreich Oliver   Henderson David   Evins A.   Culhane Melissa   Walsh Jared  

Psychopharmacology, Vol. 202, Iss. 1-3, 2009-01 ,pp. : 411-417

Springer Publishing Company

Access to resources Recommend Favorite

Verapamil for preventing adverse cardiovascular events

By  

Inpharma, Vol. 1, Iss. 1385, 2003-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite